- Superior long-term patency to synthetic grafts
- Good long-term patency even with poor run-off
- Lower infection rate than ptfe
- Ease of handling
Supplier: Bio Nova International Pty Ltd
Omniflow II for Peripheral Bypass is a Biosynthetic Vascular Prosthesis indicated when a viable saphenous vein is not available. Clinical evidence shows that Omniflow II is superior to synthetic grafts.
Price Guide: POA